For the Inventor, By the Inventor

Enter assignee name

Stockholm, Sweden

Biogaia Ab

USPTO Granted Patents = 50

CIPO Patents = 44

EPO Patents = 28

Trademarks = 24

Forward Citations = 275

Loading Chart...

Loading Chart...

61 inventors (with patents filed for the assignee):

Bo Mollstam (19 out of 26 patents)

Eamonn Connolly (18 out of 22 patents)

Stefan Roos (8 out of 10 patents)

4. Wolfgang Kunze (6 out of 6 patents)

5. John Bienenstock (6 out of 9 patents)

6. James Versalovic (4 out of 4 patents)

7. Bo Möllstam (4 out of 4 patents)

8. Elisabeth Sjoberg (4 out of 6 patents)

9. Ivan A Casas (4 out of 10 patents)

10. Robert Allen Britton (3 out of 3 patents)

11. Laura Rae McCabe (3 out of 4 patents)

12. Bernard Berger (2 out of 7 patents)

13. Clara Lucia Garcia-Rodenas (2 out of 26 patents)

14. Melissa Lepage (2 out of 3 patents)

15. Catherine Ngom-Bru (2 out of 5 patents)

Core Competencies:

Probiotic Bacteria

Lactic Acid Bacteria

Microbiota Dysbiosis

Infantile Colic

Gastrointestinal Pain

Bacterial Strains

Dental Caries

T-Reg Deficiency

Breast Milk Feeding

Enteropathogenic Infections

Melatonin Supporting Bacteria

Therapeutic Microvesicles

50 patents: Sort by Forward Citations

1. 12318412 - andfor use in the treatment or prevention of diabetes and bowel diseases (2025-06-03),

2. 12295975 - Serotonin producing bacteria (2025-05-13),

3. 12201656 - Selection of bacterial strains useful in allergy treatment (2025-01-21),

4. 11976268 - Method for adaptation (2024-05-07),

5. 11911424 - Selection and use of melatonin supporting bacteria to reduce infantile colic (2024-02-27),

6. 11857582 - Therapeutic microvesicles of probiotic bacteria (2024-01-02),

7. 11730780 - Lactic acid bacteria, methods and uses thereof (2023-08-22),

8. 11701397 - Use offor recovery of microbiota dysbiosis in early life (2023-07-18),

9. 11602551 - Use of inosine for the treatment of t-reg deficiency (2023-03-14),

10. 11371985 - Selection of agents modulating gastrointestinal pain (2022-06-28),

11. 11369646 - Use offor recovery of microbiota dysbiosis in early life (2022-06-28),

12. 11285181 - Lactic acid bacteria, methods and uses thereof (2022-03-29),

13. 11135255 - Selection of bacterial strains useful in allergy treatment (2021-10-05),

14. 10898529 - Production and use of bacterial histamine (2021-01-26),

15. 10656141 - Selection of agents modulating gastrointestinal pain (2020-05-19),

BioGaia AB is a Swedish healthcare company that develops, sells, and markets probiotic products worldwide. The company's products are based on Lactobacillus reuteri, a type of beneficial bacteria that offers various health benefits. BioGaia focuses on products for gut health, dental health, and immune system support. Their product portfolio includes drops, chewable tablets, and oral health products. With a strong commitment to research and quality, BioGaia aims to improve people's health and well-being through innovative probiotic solutions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

50 Patents

#21 in Stockholm

#132 in Sweden

#13,575 in the World

Stockholm, Sweden

Biogaia Ab

Forward Citations = 275

61 inventors:

Bo Mollstam (19 out of 26 patents)

Eamonn Connolly (18 out of 22 patents)

Stefan Roos (8 out of 10 patents)

4. Wolfgang Kunze (6 out of 6 patents)

5. John Bienenstock (6 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…